Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Kaplan

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Ophthalmology Science|June 3, 2024
Performance of Automated Machine Learning in Predicting Outcomes of Pneumatic RetinopexyArina Nisanova, Arefeh Yavary, Jordan Deaner, et al.
Southern African Journal of HIV Medicine|December 8, 2022
Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender womenLinda-Gail Bekker, Danielle Giovenco, Stefan Baral, et al.
Journal of the National Cancer Institute|April 29, 2014
ResponseChristopher G Smith, Hannah West, Rebecca Harris, et al.
International Journal of Cancer|July 16, 2021
Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancerKatie Watts, Christopher Wills, Ayman Madi, et al.
Journal of the National Cancer Institute|July 16, 2013
Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesisChristopher G Smith, Hannah West, Rebecca Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximabChristopher G Smith, David Fisher, Bart Claes, et al.
Nature Reviews. Clinical Oncology|April 23, 2014
Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Gut|November 1, 2016
High hospital research participation and improved colorectal cancer survival outcomes: a population-based studyAmy Downing, Eva Ja Morris, Neil Corrigan, et al.
Lancet (London, England)|January 24, 2017
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyHashim U Ahmed, Ahmed El-Shater Bosaily, Louise C Brown, et al.
Nature Reviews. Clinical Oncology|September 13, 2017
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Ophthalmology Science|June 3, 2024
Performance of Automated Machine Learning in Predicting Outcomes of Pneumatic RetinopexyArina Nisanova, Arefeh Yavary, Jordan Deaner, et al.
Southern African Journal of HIV Medicine|December 8, 2022
Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender womenLinda-Gail Bekker, Danielle Giovenco, Stefan Baral, et al.
Journal of the National Cancer Institute|April 29, 2014
ResponseChristopher G Smith, Hannah West, Rebecca Harris, et al.
International Journal of Cancer|July 16, 2021
Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancerKatie Watts, Christopher Wills, Ayman Madi, et al.
Journal of the National Cancer Institute|July 16, 2013
Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesisChristopher G Smith, Hannah West, Rebecca Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximabChristopher G Smith, David Fisher, Bart Claes, et al.
Nature Reviews. Clinical Oncology|April 23, 2014
Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Gut|November 1, 2016
High hospital research participation and improved colorectal cancer survival outcomes: a population-based studyAmy Downing, Eva Ja Morris, Neil Corrigan, et al.
Lancet (London, England)|January 24, 2017
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyHashim U Ahmed, Ahmed El-Shater Bosaily, Louise C Brown, et al.
Nature Reviews. Clinical Oncology|September 13, 2017
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Pageof 15